The DOI matches its Crossref record; 155 of the 155 references it cites were found in a registry or an index.
Epidemiology of Parkinson's disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Hughes, A. J., Daniel, S. E., Kilford, L., & Lees, A. J. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.3.181 · Cited by 10,378
Clinical diagnostic criteria for dementia associated with Parkinson’s disease
Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., Broe, G. A., Cummings, J., Dickson, D. W., Gauthier, S., et al. (2007) · Movement Disorders · doi:10.1002/mds.21507 · Cited by 3,027
Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030
Dorsey, E. R., Constantinescu, R., Thompson, J. P., Biglan, K. M., Holloway, R. G., Kieburtz, K., Marshall, F. J., Ravina, B. M., Schifitto, G., Siderowf, A., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000247740.47667.03 · Cited by 2,472
The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
Hely, M. A., Reid, W. G. J., Adena, M. A., Halliday, G. M., & Morris, J. G. L. (2008) · Movement Disorders · doi:10.1002/mds.21956 · Cited by 2,246
The prevalence of Parkinson's disease: a systematic review and meta-analysis
Pringsheim, T., Jette, N., Frolkis, A., & Steeves, T. D. L. (2014) · Movement Disorders · doi:10.1002/mds.25945 · Cited by 2,188
International Parkinson's Disease Genomics Consortium (IPDGC), Nalls, M. A., Parkinson's Study Group (PSG) Parkinson's Research: The Organized GENetics Initiative (PROGENI), 23andMe, GenePD, NeuroGenetics Research Consortium (NGRC), Hussman Institute of Human Genomics (HIHG), Investigator, T. A. J. D., (CHARGE), C. F. H. A. A. R. I. G. E., North American Brain Expression Consortium (NABEC), et al. (2014) · Nature Genetics · doi:10.1038/ng.3043 · Cited by 1,895
A systematic review of prevalence studies of dementia in Parkinson's disease
Aarsland, D., Zaccai, J., & Brayne, C. (2005) · Movement Disorders · doi:10.1002/mds.20527 · Cited by 1,689
Rotenone, Paraquat, and Parkinson’s Disease
Tanner, C. M., Kamel, F., Ross, G. W., Hoppin, J. A., Goldman, S. M., Korell, M., Marras, C., Bhudhikanok, G. S., Kasten, M., Chade, A. R., et al. (2011) · Environmental Health Perspectives · doi:10.1289/ehp.1002839 · Cited by 1,475
Prevalence and Characteristics of Dementia in Parkinson Disease: An 8-Year Prospective Study
Aarsland, D., Andersen, K., Larsen, J. P., & Lolk, A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.387 · Cited by 1,401
The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service
Hughes, A. J., Daniel, S. E., Ben‐Shlomo, Y., & Lees, A. J. (2002) · Brain · doi:10.1093/brain/awf080 · Cited by 1,251
Epidemiology and etiology of Parkinson's disease: a review of the evidence
Wirdefeldt, K., Adami, H.-O., Cole, P., Trichopoulos, D., & Mandel, J. (2011) · European Journal of Epidemiology · doi:10.1007/s10654-011-9581-6 · Cited by 1,199
Dubois, B., Burn, D., Goetz, C., Aarsland, D., Brown, R. G., Broe, G. A., Dickson, D., Duyckaerts, C., Cummings, J., Gauthier, S., et al. (2007) · Movement Disorders · doi:10.1002/mds.21844 · Cited by 1,082
Evolution of cognitive dysfunction in an incident Parkinson's disease cohort
Williams-Gray, C. H., Foltynie, T., Brayne, C. E. G., Robbins, T. W., & Barker, R. A. (2007) · Brain · doi:10.1093/brain/awm111 · Cited by 934
‘Rejuvenation’ protects neurons in mouse models of Parkinson’s disease
Chan, C. S., Guzman, J. N., Ilijic, E., Mercer, J. N., Rick, C., Tkatch, T., Meredith, G. E., & Surmeier, D. J. (2007) · Nature · doi:10.1038/nature05865 · Cited by 904
Parkinson Disease in Twins: An Etiologic Study
Tanner, C. M., Ottman, R., Goldman, S. M., Ellenberg, J., Chan, P., Mayeux, R., & Langston, J. W. (1999) · JAMA · doi:10.1001/jama.281.4.341 · Cited by 867
de Rijk, M. C., Tzourio, C., Breteler, M. M., Dartigues, J. F., Amaducci, L., Lopez-Pousa, S., Manubens-Bertran, J. M., Alperovitch, A., & Rocca, W. A. (1997) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.62.1.10 · Cited by 833
A meta‐analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease
Hernán, M. A., Takkouche, B., Caamaño‐Isorna, F., & Gestal‐Otero, J. J. (2002) · Annals of Neurology · doi:10.1002/ana.10277 · Cited by 818
Association of coffee and caffeine intake with the risk of Parkinson disease
Ross, G. W. (2000) · JAMA · doi:10.1001/jama.283.20.2674 · Cited by 778
Missing pieces in the Parkinson's disease puzzle
Obeso, J. A., Rodriguez-Oroz, M. C., Goetz, C. G., Marin, C., Kordower, J. H., Rodriguez, M., Hirsch, E. C., Farrer, M., Schapira, A. H. V., & Halliday, G. (2010) · Nature Medicine · doi:10.1038/nm.2165 · Cited by 734
Are men at greater risk for Parkinson's disease than women?
Wooten, G. F. (2004) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.020982 · Cited by 695
The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort
Williams-Gray, C. H., Mason, S. L., Evans, J. R., Foltynie, T., Brayne, C., Robbins, T. W., & Barker, R. A. (2013) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-305277 · Cited by 681
Prospective Study of Caffeine Consumption and Risk of Parkinson’s Disease in Men and Women
Ascherio, A., Zhang, S. M., Hernán, M. A., Kawachi, I., Colditz, G. A., Speizer, F. E., & Willett, W. C. (2001) · Annals of Neurology · doi:10.1002/ana.1052 · Cited by 677
Inhibition of monoamine oxidase B in the brains of smokers
Fowler, J. S., Volkow, N. D., Wang, G.-J., Pappas, N., Logan, J., MacGregor, R., Alexoff, D., Shea, C., Schlyer, D., Wolf, A. P., et al. (1996) · Nature · doi:10.1038/379733a0 · Cited by 656
Prevalence and incidence of Parkinson's disease in Europe
von Campenhausen, S., Bornschein, B., Wick, R., Bötzel, K., Sampaio, C., Poewe, W., Oertel, W., Siebert, U., Berger, K., & Dodel, R. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.04.007 · Cited by 625
Costello, S., Cockburn, M., Bronstein, J., Zhang, X., & Ritz, B. (2009) · American Journal of Epidemiology · doi:10.1093/aje/kwp006 · Cited by 581
Aarsland, D., Bronnick, K., Ehrt, U., De Deyn, P. P., Tekin, S., Emre, M., & Cummings, J. L. (2007) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.083113 · Cited by 521
Prevalence of Parkinson's disease in the elderly: The Rotterdam Study
de Rijk, M. C., Breteler, M. M. B., Graveland, G. A., Ott, A., Grobbee, D. E., van der Meche, F. G. A., & Hofman, A. (1995) · Neurology · doi:10.1212/wnl.45.12.2143 · Cited by 488
Dementia and survival in Parkinson disease: A 12-year population study
Buter, T. C., van den Hout, A., Matthews, F. E., Larsen, J. P., Brayne, C., & Aarsland, D. (2008) · Neurology · doi:10.1212/01.wnl.0000306632.43729.24 · Cited by 451
Pesticide exposure and risk for Parkinson's disease
Ascherio, A., Chen, H., Weisskopf, M. G., O'Reilly, E., McCullough, M. L., Calle, E. E., Schwarzschild, M. A., & Thun, M. J. (2006) · Annals of Neurology · doi:10.1002/ana.20904 · Cited by 445
Burn, D. J. (2006) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.081711 · Cited by 436
Baltazar, M. T., Dinis-Oliveira, R. J., de Lourdes Bastos, M., Tsatsakis, A. M., Duarte, J. A., & Carvalho, F. (2014) · Toxicology Letters · doi:10.1016/j.toxlet.2014.01.039 · Cited by 410
Relationships between age and late progression of Parkinson's disease: a clinico-pathological study
Kempster, P. A., O'Sullivan, S. S., Holton, J. L., Revesz, T., & Lees, A. J. (2010) · Brain · doi:10.1093/brain/awq059 · Cited by 410
Risk tables for parkinsonism and Parkinson’s disease
Elbaz, A., Bower, J. H., Maraganore, D. M., McDonnell, S. K., Peterson, B. J., Ahlskog, J. E., Schaid, D. J., & Rocca, W. A. (2002) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(01)00425-5 · Cited by 377
Cigarette smoking and protection from Parkinson's disease: False association or etiologic clue?
Morens, D. M., Grandinetti, A., Reed, D., White, L. R., & Ross, G. W. (1995) · Neurology · doi:10.1212/wnl.45.6.1041 · Cited by 370
Pooled Analysis of Tobacco Use and Risk of Parkinson Disease
Ritz, B., Ascherio, A., Checkoway, H., Marder, K. S., Nelson, L. M., Rocca, W. A., Ross, G. W., Strickland, D., Van Den Eeden, S. K., & Gorell, J. (2007) · Archives of Neurology · doi:10.1001/archneur.64.7.990 · Cited by 370
Parkinson’s disease risk from ambient exposure to pesticides
Wang, A., Costello, S., Cockburn, M., Zhang, X., Bronstein, J., & Ritz, B. (2011) · European Journal of Epidemiology · doi:10.1007/s10654-011-9574-5 · Cited by 349
Exposure to pesticides or solvents and risk of Parkinson disease
Pezzoli, G., & Cereda, E. (2013) · Neurology · doi:10.1212/wnl.0b013e318294b3c8 · Cited by 331
Mortality in Parkinson's disease: A systematic review and meta‐analysis
Macleod, A. D., Taylor, K. S. M., & Counsell, C. E. (2014) · Movement Disorders · doi:10.1002/mds.25898 · Cited by 328
Anti-inflammatory drugs and risk of Parkinson disease: A meta-analysis
Gagne, J. J., & Power, M. C. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d5a4a3 · Cited by 322
Parkinson's disease and pesticides: a toxicological perspective
HATCHER, J., PENNELL, K., & MILLER, G. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.03.007 · Cited by 319
Professional exposure to pesticides and Parkinson disease
Elbaz, A., Clavel, J., Rathouz, P. J., Moisan, F., Galanaud, J., Delemotte, B., Alpérovitch, A., & Tzourio, C. (2009) · Annals of Neurology · doi:10.1002/ana.21717 · Cited by 317
Self-citationWhen Does Parkinson Disease Start?
Savica, R., Rocca, W. A., & Ahlskog, J. E. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.135 · Cited by 312
Hobson, P., & Meara, J. (2004) · Movement Disorders · doi:10.1002/mds.20216 · Cited by 312
Progression of Parkinson's disease in the clinical phase: potential markers
Maetzler, W., Liepelt, I., & Berg, D. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70291-1 · Cited by 305
What predicts mortality in Parkinson disease?: A prospective population-based long-term study
Forsaa, E. B., Larsen, J. P., Wentzel-Larsen, T., & Alves, G. (2010) · Neurology · doi:10.1212/wnl.0b013e3181f61311 · Cited by 302
The association of incident dementia with mortality in PD
Levy, G., Tang, M.-X., Louis, E. D., Côté, L. J., Alfaro, B., Mejia, H., Stern, Y., & Marder, K. (2002) · Neurology · doi:10.1212/01.wnl.0000036610.36834.e0 · Cited by 297
Head injury and Parkinson's disease risk in twins
Goldman, S. M., Tanner, C. M., Oakes, D., Bhudhikanok, G. S., Gupta, A., & Langston, J. W. (2006) · Annals of Neurology · doi:10.1002/ana.20882 · Cited by 297
Head injury and risk of Parkinson disease: A systematic review and meta‐analysis
Jafari, S., Etminan, M., Aminzadeh, F., & Samii, A. (2013) · Movement Disorders · doi:10.1002/mds.25458 · Cited by 282
Costa, J., Lunet, N., Santos, C., Santos, J., & Vaz-Carneiro, A. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-091525 · Cited by 247
Dopamine‐related personality traits in Parkinson's disease
Menza, M. A., Golbe, L. I., Cody, R. A., & Forman, N. E. (1993) · Neurology · doi:10.1212/wnl.43.3_part_1.505 · Cited by 247
Parkinson’s disease and cancer risk: a systematic review and meta-analysis
Bajaj, A., Driver, J. A., & Schernhammer, E. S. (2010) · Cancer Causes & Control · doi:10.1007/s10552-009-9497-6 · Cited by 244
Schwarzschild, M. A., Ascherio, A., Beal, M. F., Cudkowicz, M. E., Curhan, G. C., Hare, J. M., Hooper, D. C., Kieburtz, K. D., Macklin, E. A., Oakes, D., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.5528 · Cited by 243
Is Pesticide Use Related to Parkinson Disease? Some Clues to Heterogeneity in Study Results
van der Mark, M., Brouwer, M., Kromhout, H., Nijssen, P., Huss, A., & Vermeulen, R. (2012) · Environmental Health Perspectives · doi:10.1289/ehp.1103881 · Cited by 238
Heterogeneity in male to female risk for Parkinson's disease
Taylor, K. S. M., Cook, J. A., & Counsell, C. E. (2007) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.104695 · Cited by 238
Caffeine, postmenopausal estrogen, and risk of Parkinson’s disease
Ascherio, A., Chen, H., Schwarzschild, M. A., Zhang, S. M., Colditz, G. A., & Speizer, F. E. (2003) · Neurology · doi:10.1212/01.wnl.0000046523.05125.87 · Cited by 234
Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease
Simon, K. C., Chen, H., Schwarzschild, M., & Ascherio, A. (2007) · Neurology · doi:10.1212/01.wnl.0000271883.45010.8a · Cited by 231
Progress in unraveling the genetic etiology of Parkinson disease in a genomic era
Verstraeten, A., Theuns, J., & Van Broeckhoven, C. (2015) · Trends in Genetics · doi:10.1016/j.tig.2015.01.004 · Cited by 226
Smoking duration, intensity, and risk of Parkinson disease
Chen, H., Huang, X., Guo, X., Mailman, R. B., Park, Y., Kamel, F., Umbach, D. M., Xu, Q., Hollenbeck, A., Schatzkin, A., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d55f38 · Cited by 223
Trichloroethylene: Parkinsonism and complex 1 mitochondrial neurotoxicity
Gash, D. M., Rutland, K., Hudson, N. L., Sullivan, P. G., Bing, G., Cass, W. A., Pandya, J. D., Liu, M., Choi, D., Hunter, R. L., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21288 · Cited by 222
Hamza, T. H., Chen, H., Hill-Burns, E. M., Rhodes, S. L., Montimurro, J., Kay, D. M., Tenesa, A., Kusel, V. I., Sheehan, P., Eaaswarkhanth, M., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002237 · Cited by 218
A population perspective on diagnostic criteria for Parkinson's disease
de Rijk, M. C., Rocca, W. A., Anderson, D. W., Melcon, M. O., Breteler, M. M. B., & Maraganore, D. M. (1997) · Neurology · doi:10.1212/wnl.48.5.1277 · Cited by 214
CYP2D6 polymorphism, pesticide exposure, and Parkinson's disease
Elbaz, A., Levecque, C., Clavel, J., Vidal, J., Richard, F., Amouyel, P., Alpérovitch, A., Chartier‐Harlin, M., & Tzourio, C. (2004) · Annals of Neurology · doi:10.1002/ana.20051 · Cited by 213
Self-citationPrognosis of Parkinson Disease: Risk of Dementia and Mortality: The Rotterdam Study
de Lau, L. M. L., Schipper, C. M. A., Hofman, A., Koudstaal, P. J., & Breteler, M. M. B. (2005) · Archives of Neurology · doi:10.1001/archneur.62.8.1265 · Cited by 211
Head trauma preceding PD: A case-control study
Bower, J. H., Maraganore, D. M., Peterson, B. J., McDonnell, S. K., Ahlskog, J. E., & Rocca, W. A. (2003) · Neurology · doi:10.1212/01.wnl.0000068008.78394.2c · Cited by 205
Serum Cholesterol Levels and the Risk of Parkinson's Disease
de Lau, L. M. L., Koudstaal, P. J., Hofman, A., & Breteler, M. M. B. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj283 · Cited by 205
Parkinson's disease: Evidence for environmental risk factors
Kieburtz, K., & Wunderle, K. B. (2013) · Movement Disorders · doi:10.1002/mds.25150 · Cited by 199
Consumption of Dairy Products and Risk of Parkinson's Disease
Chen, H., O'Reilly, E., McCullough, M. L., Rodriguez, C., Schwarzschild, M. A., Calle, E. E., Thun, M. J., & Ascherio, A. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwk089 · Cited by 188
Solvent exposures and parkinson disease risk in twins
Goldman, S. M., Quinlan, P. J., Ross, G. W., Marras, C., Meng, C., Bhudhikanok, G. S., Comyns, K., Korell, M., Chade, A. R., Kasten, M., et al. (2012) · Annals of Neurology · doi:10.1002/ana.22629 · Cited by 187
Systematic review of the prevalence and incidence of Parkinson's disease in Asia
Muangpaisan, W., Hori, H., & Brayne, C. (2009) · Journal of Epidemiology · doi:10.2188/jea.je20081034 · Cited by 185
Plantation Work and Risk of Parkinson Disease in a Population-Based Longitudinal Study
Petrovitch, H., Ross, G. W., Abbott, R. D., Sanderson, W. T., Sharp, D. S., Tanner, C. M., Masaki, K. H., Blanchette, P. L., Popper, J. S., Foley, D., et al. (2002) · Archives of Neurology · doi:10.1001/archneur.59.11.1787 · Cited by 185
Beyer, M. K., Herlofson, K., Årsland, D., & Larsen, J. P. (2001) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2001.00191.x · Cited by 183
Tan, L. C., Koh, W.-P., Yuan, J.-M., Wang, R., Au, W.-L., Tan, J. H., Tan, E.-K., & Yu, M. C. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm338 · Cited by 183
Smoking and Parkinson’s disease in twins
Tanner, C. M., Goldman, S. M., Aston, D. A., Ottman, R., Ellenberg, J., Mayeux, R., & Langston, J. W. (2002) · Neurology · doi:10.1212/wnl.58.4.581 · Cited by 182
Van Maele-Fabry, G., Hoet, P., Vilain, F., & Lison, D. (2012) · Environment International · doi:10.1016/j.envint.2012.05.004 · Cited by 182
Prospective study of coffee consumption and risk of Parkinson’s disease
Sääksjärvi, K., Knekt, P., Rissanen, H., Laaksonen, M. A., Reunanen, A., & Männistö, S. (2008) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602788 · Cited by 182
Survival Study of Parkinson Disease in Olmsted County, Minnesota
Elbaz, A., Bower, J. H., Peterson, B. J., Maraganore, D. M., McDonnell, S. K., Ahlskog, J. E., Schaid, D. J., & Rocca, W. A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.1.91 · Cited by 179
Self-citationPredictors of Survival in Patients With Parkinson Disease
Schootman, M. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.2370 · Cited by 175
Prospective Cohort Study of Type 2 Diabetes and the Risk of Parkinson's Disease
Driver, J. A., Smith, A., Buring, J. E., Gaziano, J. M., Kurth, T., & Logroscino, G. (2008) · Diabetes Care · doi:10.2337/dc08-0688 · Cited by 168
Auyeung, M., Tsoi, T. H., Mok, V., Cheung, C. M., Lee, C. N., Li, R., & Yeung, E. (2012) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301590 · Cited by 166
Aldehyde dehydrogenase variation enhances effect of pesticides associated with Parkinson disease
Fitzmaurice, A. G., Rhodes, S. L., Cockburn, M., Ritz, B. R., & Bronstein, J. M. (2014) · Neurology · doi:10.1212/wnl.0000000000000083 · Cited by 163
The cause of death in idiopathic Parkinson’s disease
Pennington, S., Snell, K., Lee, M. W., & Walker, R. W. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.04.010 · Cited by 162
Persistent organochlorine pesticides in serum and risk of Parkinson disease
Weisskopf, M. G., Knekt, P., O'Reilly, E. J., Lyytinen, J., Reunanen, A., Laden, F., Altshul, L., & Ascherio, A. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d76a93 · Cited by 162
Plasma Urate and Parkinson's Disease in the Atherosclerosis Risk in Communities (ARIC) Study
Chen, H., Mosley, T. H., Alonso, A., & Huang, X. (2009) · American Journal of Epidemiology · doi:10.1093/aje/kwp033 · Cited by 161
Parkinson disease and smoking revisited: Ease of quitting is an early sign of the disease
Ritz, B., Lee, P.-C., Lassen, C. F., & Arah, O. A. (2014) · Neurology · doi:10.1212/wnl.0000000000000879 · Cited by 160
Meta-analysis of the relationship between Parkinson disease and melanoma
Liu, R., Gao, X., Lu, Y., & Chen, H. (2011) · Neurology · doi:10.1212/wnl.0b013e31821e554e · Cited by 160
PPAR: a therapeutic target in Parkinson’s disease
Chaturvedi, R. K., & Beal, M. F. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05388.x · Cited by 159
Anxious personality predicts an increased risk of Parkinson's disease
Bower, J. H., Grossardt, B. R., Maraganore, D. M., Ahlskog, J. E., Colligan, R. C., Geda, Y. E., Therneau, T. M., & Rocca, W. A. (2010) · Movement Disorders · doi:10.1002/mds.23230 · Cited by 158
What is the evidence for a premorbid parkinsonian personality: A systematic review
Ishihara, L., & Brayne, C. (2006) · Movement Disorders · doi:10.1002/mds.20980 · Cited by 153
Dietary and lifestyle variables in relation to incidence of Parkinson’s disease in Greece
Kyrozis, A., Ghika, A., Stathopoulos, P., Vassilopoulos, D., Trichopoulos, D., & Trichopoulou, A. D. (2013) · European Journal of Epidemiology · doi:10.1007/s10654-012-9760-0 · Cited by 151
Epigenetic mechanisms in Parkinson's disease
Feng, Y., Jankovic, J. J., & Wu, Y. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.12.017 · Cited by 146
Dutheil, F., Beaune, P. H., Tzourio, C., Loriot, M., & Elbaz, A. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.101 · Cited by 146
Self-citationSchoenberg, B. S., Osuntokun, B. O., Adeuja, A. O. G., Bademosi, O., Nottidge, V. A., Anderson, D. W., & Haerer, A. F. (1988) · Neurology · doi:10.1212/wnl.38.4.645 · Cited by 145
Statins, plasma cholesterol, and risk of Parkinson's disease: A prospective study
Huang, X., Alonso, Á., Guo, X., Umbach, D. M., Lichtenstein, M. L., Ballantyne, C. M., Mailman, R. B., Mosley, T. H., & Chen, H. (2015) · Movement Disorders · doi:10.1002/mds.26152 · Cited by 145
Risk and protective factors for Parkinson's disease: A study in Swedish twins
Wirdefeldt, K., Gatz, M., Yudi Pawitan, Y., & Pedersen, N. L. (2004) · Annals of Neurology · doi:10.1002/ana.20307 · Cited by 144
Polygenic risk of P arkinson disease is correlated with disease age at onset
Escott‐Price, V., Nalls, M. A., Morris, H. R., Lubbe, S. J., Brice, A., Gasser, T., Heutink, P., Wood, N. W., Hardy, J., Singleton, A., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24335 · Cited by 143
Marras, C., McDermott, M., Rochon, P. A., Tanner, C. M., Naglie, G., Rudolph, A., Lang, A. E., & the Parkinson Study Group (2005) · Neurology · doi:10.1212/01.wnl.0000148603.44618.19 · Cited by 143
Current Evidence for Neuroprotective Effects of Nicotine and Caffeine Against Parkinson??s Disease
Ross, G. W., & Petrovitch, H. (2001) · Drugs & Aging · doi:10.2165/00002512-200118110-00001 · Cited by 143
Changing epidemiology of Parkinson’s disease in southwestern Finland
Kuopio, A., Marttila, R. J., Helenius, H. Y. M., & Rinne, U. K. (1999) · Neurology · doi:10.1212/wnl.52.2.302 · Cited by 137
Schwarzschild, M. A., Xu, K., Öztaş, E., Petzer, J. P., Castagnoli, K., Castagnoli, N. J., & Chen, J. (2003) · Neurology · doi:10.1212/01.wnl.0000095214.53646.72 · Cited by 133
Tansey, M. G. (2007) · Frontiers in bioscience · doi:10.2741/2713 · Cited by 126
The association between ambient exposure to organophosphates and Parkinson's disease risk
Wang, A. W., Cockburn, M., Ly, T., Bronstein, J. M., & Ritz, B. R. (2014) · Occupational and Environmental Medicine · doi:10.1136/oemed-2013-101394 · Cited by 125
Discontinuation of statin therapy associates with Parkinson disease: A population-based study
Lee, Y., Lin, C., Wu, R., Lin, M.-S., Lin, J., Chang, C., & Lai, M. (2013) · Neurology · doi:10.1212/wnl.0b013e31829d873c · Cited by 122
Smoking and Parkinson's disease: Does nicotine affect α-synuclein fibrillation?
Hong, D.-P., Fink, A. L., & Uversky, V. N. (2008) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2008.09.026 · Cited by 121
An emerging role of PARK2 in cancer
Xu, L., Lin, D., Yin, D., & Koeffler, H. P. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1107-0 · Cited by 120
Parkinson's disease in Africa: A systematic review of epidemiologic and genetic studies
Okubadejo, N. U., Bower, J. H., Rocca, W. A., & Maraganore, D. M. (2006) · Movement Disorders · doi:10.1002/mds.21153 · Cited by 117
Moisan, F., Spinosi, J., Delabre, L., Gourlet, V., Mazurie, J.-L., Bénatru, I., Goldberg, M., Weisskopf, M. G., Imbernon, E., Tzourio, C., et al. (2015) · Environmental Health Perspectives · doi:10.1289/ehp.1307970 · Cited by 115
Self-citationHead injury, alpha‐synuclein Rep1, and Parkinson's disease
Goldman, S. M., Kamel, F., Ross, G. W., Jewell, S. A., Bhudhikanok, G. S., Umbach, D. M., Marras, C., Hauser, R. A., Jankovic, J. J., Factor, S. A., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22499 · Cited by 114
Heritability of Parkinson disease in Swedish twins: a longitudinal study
Wirdefeldt, K., Gatz, M., Reynolds, C. A., Prescott, C. A., & Pedersen, N. L. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.02.017 · Cited by 113
Parkinson Study Group (2013) · Movement Disorders · doi:10.1002/mds.25639 · Cited by 113
Mortality from Parkinson's disease: A population‐based prospective study (NEDICES)
Posada, I. J., Benito‐León, J., Louis, E. D., Trincado, R., Villarejo‐Galende, A., Medrano, M. J., & Bermejo‐Pareja, F. (2011) · Movement Disorders · doi:10.1002/mds.23921 · Cited by 105
Antihypertensive Agents and Risk of Parkinson's Disease: A Nationwide Cohort Study
Lee, Y., Lin, C., Wu, R., Lin, J., Chang, C., & Lai, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098961 · Cited by 105
Mortality in Parkinson's disease: A 20‐year follow‐up study
Diem‐Zangerl, A., Seppi, K., Wenning, G. K., Trinka, E., Ransmayr, G. N., Oberaigner, W., & Poewe, W. H. (2009) · Movement Disorders · doi:10.1002/mds.22414 · Cited by 105
Parkinson's prevalence estimated by a state registry
Strickland, D., & Bertoni, J. M. (2003) · Movement Disorders · doi:10.1002/mds.10619 · Cited by 104
Serum Urate and the Risk of Parkinson's Disease: Results From a Meta-Analysis
Shen, C., Guo, Y. C., Luo, W. F., Chen, L., & Ding, M. (2013) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100012981 · Cited by 100
Mortality in Parkinson's disease, a 20‐year follow‐up study
Diem‐Zangerl, A., Seppi, K., Oberaigner, W., & Poewe, W. H. (2010) · Movement Disorders · doi:10.1002/mds.22934 · Cited by 99
Solvents and Parkinson disease: A systematic review of toxicological and epidemiological evidence
Lock, E. A., Zhang, J., & Checkoway, H. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.11.016 · Cited by 98
Chiò, A., Magnani, C., & Schiffer, D. (1998) · Movement Disorders · doi:10.1002/mds.870130305 · Cited by 97
Pathophysiological roles for purines
Morelli, M., Carta, A. R., Kachroo, A., & Schwarzschild, M. A. (2010) · Progress in brain research · doi:10.1016/s0079-6123(10)83010-9 · Cited by 96
Cigarette smoking in Parkinson's disease: Influence on disease progression
Alves, G. W., Kurz, M. W., Lie, S. A., & Larsen, J. O. (2004) · Movement Disorders · doi:10.1002/mds.20117 · Cited by 94
Mendelian randomization of serum urate and parkinson disease progression
Simon, K. C., Eberly, S. W., Gao, X., Oakes, D., Tanner, C. M., Shoulson, I., Fahn, S., Schwarzschild, M. A., Ascherio, A., & on behalf of the Parkinson Study Group (2014) · Annals of Neurology · doi:10.1002/ana.24281 · Cited by 84
Serum Cholesterol and the Progression of Parkinson's Disease: Results from DATATOP
Huang, X., Auinger, P., Eberly, S. W., Oakes, D., Schwarzschild, M. A., Ascherio, A., Mailman, R. B., Chen, H., & for the Parkinson Study Group DATATOP Investigators (2011) · PLoS ONE · doi:10.1371/journal.pone.0022854 · Cited by 82
Premorbid personality of Parkinson patients.
Poewe, W. H., Gerstenbrand, F., Ransmayr, G. N., & Plörer, S. (1983) · PubMed · Cited by 79
Genetic risk and age in Parkinson's disease: Continuum not stratum
Nalls, M. A., Escott‐Price, V., Williams, N. M., Lubbe, S. J., Keller, M. F., Morris, H. R., & Singleton, A. (2015) · Movement Disorders · doi:10.1002/mds.26192 · Cited by 76
Familial aggregation of Parkinson's disease: A meta‐analysis
Thacker, E. L., & Ascherio, A. (2008) · Movement Disorders · doi:10.1002/mds.22067 · Cited by 75
Nicotine from edible Solanaceae and risk of Parkinson disease
Nielsen, S. S., Franklin, G. M., Longstreth, W. T., Swanson, P. D., & Checkoway, H. (2013) · Annals of Neurology · doi:10.1002/ana.23884 · Cited by 71
Inflammation and dopaminergic neuronal loss in Parkinson's disease: a complex matter
Hartmann, A., Hunot, S., & Hirsch, É. C. (2003) · Experimental Neurology · doi:10.1016/j.expneurol.2003.08.004 · Cited by 70
Environmental tobacco smoke and Parkinson's disease
Nielsen, S. S., Gallagher, L. G., Lundin, J. I., Longstreth, W. T., Smith‐Weller, T., Franklin, G. M., Swanson, P. D., & Checkoway, H. (2011) · Movement Disorders · doi:10.1002/mds.24012 · Cited by 70
Hobson, P., Meara, J., & Ishihara-Paul, L. (2010) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.198689 · Cited by 69
Parkinson's Disease and Cancer: A Register-based Family Study
Wirdefeldt, K., Weibull, C. E., Chen, H., Kamel, F., Lundholm, C., Fang, F., & Ye, W. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kwt232 · Cited by 68
Perez, F., Helmer, C., Foubert‐Samier, A., Auriacombe, S., Dartigues, J., & Tison, F. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.09.230 · Cited by 66
Head injury and Parkinson's disease: A population‐based study
Fang, F., Chen, H., Feldman, A. L., Kamel, F., Ye, W., & Wirdefeldt, K. (2012) · Movement Disorders · doi:10.1002/mds.25143 · Cited by 63
Lee, P., Rhodes, S. L., Sinsheimer, J. S., Bronstein, J. M., & Ritz, B. R. (2013) · Environment International · doi:10.1016/j.envint.2013.03.004 · Cited by 63
Statin use and risk of Parkinson’s disease: a meta-analysis of observational studies
Undela, K., Gudala, K., Malla, S., & Bansal, D. (2012) · Journal of Neurology · doi:10.1007/s00415-012-6606-3 · Cited by 62
Time trends in the incidence of parkinsonism in Olmsted County, Minnesota
Rocca, W. A., Bower, J. H., McDonnell, S. K., Peterson, B. J., & Maraganore, D. M. (2001) · Neurology · doi:10.1212/wnl.57.3.462 · Cited by 54
Rhodes, S. L., Fitzmaurice, A. G., Cockburn, M., Bronstein, J. M., Sinsheimer, J. S., & Ritz, B. R. (2013) · Environmental Research · doi:10.1016/j.envres.2013.08.001 · Cited by 53
Zhang, Z., Anderson, D. W., Huang, J., Li, H., Hong, X., Wei, J., Yang, E., & Maraganore, D. M. (2003) · Movement Disorders · doi:10.1002/mds.10445 · Cited by 51
Galanaud, J. ‐., Elbaz, A., Clavel, J., Vidal, J., Corrèze, J., Alpérovitch, A., & Tzourio, C. (2004) · Movement Disorders · doi:10.1002/mds.20307 · Cited by 51
Self-citationEtiologies of P arkinsonism in a Century‐Long Autopsy‐Based Cohort
Horvath, J. E., Burkhard, P. R., Bouras, C., & Kövari, E. (2012) · Brain Pathology · doi:10.1111/j.1750-3639.2012.00611.x · Cited by 50
Prediction Model of Parkinson's Disease Based on Antiparkinsonian Drug Claims
Moisan, F., Gourlet, V., Mazurie, J.-L., Dupupet, J.-L., Houssinot, J., Goldberg, M., Imbernon, E., Tzourio, C., & Elbaz, A. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwr081 · Cited by 48
Self-citationOccupational exposure in Parkinsonian disorders: A 43-year prospective cohort study in men
Feldman, A. L., Johansson, A. L. V., Nise, G., Gatz, M., Pedersen, N. L., & Wirdefeldt, K. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.06.009 · Cited by 45
Passive smoking and Parkinson disease
Mellick, G. D., GARTNER, C. E., Silburn, P. A., & Battistutta, D. (2006) · Neurology · doi:10.1212/01.wnl.0000223618.53129.56 · Cited by 41
Novelty seeking and introversion do not predict the long-term risk of Parkinson disease
Arabia, G., Grossardt, B. R., Colligan, R. C., Bower, J. H., Maraganore, D. M., Ahlskog, J. E., Geda, Y. E., & Rocca, W. A. (2010) · Neurology · doi:10.1212/wnl.0b013e3181ea15fd · Cited by 41
Validity of mortality data for Parkinson's disease.
Phillips, N. J., Reay, J., & Martyn, C. N. (1999) · Journal of Epidemiology & Community Health · doi:10.1136/jech.53.9.587 · Cited by 39
Duarte, J., Olmos, L. M. G., Mendoza, A. C., & Clavería, L. E. (2012) · Acta Neurologica Scandinavica · doi:10.1111/ane.12003 · Cited by 38
Calcium channel blocker use and risk of Parkinson's disease: a meta-analysis
Lang, Y., Gong, D., & Fan, Y. (2015) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3781 · Cited by 37
Susceptibility loci for pigmentation and melanoma in relation to Parkinson's disease
Dong, J., Gao, J., Nalls, M. A., Gao, X., Huang, X., Han, J., Singleton, A., & Chen, H. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.12.020 · Cited by 31
Evaluation of antiparkinsonian drugs in pharmacy records as a marker for Parkinson's disease.
van de Vijver, D. A. M. C., Porsius, A. J., de Boer, A., Stricker, B. H. C., Breteler, M. M. B., Roos, R. A. C., & Hewison, J. (2001) · Pharmacy World & Science · doi:10.1023/a:1011807919632 · Cited by 30
Head injuries and Parkinson's disease in a case-control study
Harris, M. A., Shen, H., Marion, S. A., Tsui, J. K. C., & Teschke, K. (2013) · Occupational and Environmental Medicine · doi:10.1136/oemed-2013-101444 · Cited by 30
Lack of Replication of the GRIN2A-by-Coffee Interaction in Parkinson Disease
Ahmed, I., Lee, P., Lill, C. M., Nielsen, S. S., Artaud, F., Gallagher, L. G., Loriot, M., Mulot, C., Nacfer, M., Liu, T., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004788 · Cited by 30
Self-citationAfter half a century of research on smoking and PD, where do we go now?
Ritz, B. R., & Rhodes, S. L. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d63aa8 · Cited by 27
LINE-1 DNA Methylation, Smoking and Risk of Parkinson's Disease
Nielsen, S. S., Checkoway, H., Butler, R. A., Nelson, H. H., Farin, F. M., Longstreth, W. T., Franklin, G. M., Swanson, P. D., & Kelsey, K. T. (2012) · Journal of Parkinson s Disease · doi:10.3233/jpd-012129 · Cited by 26
Under-reporting of Parkinson's disease on death certificates: A population-based study (NEDICES)
Benito‐León, J., Louis, E. D., Villarejo‐Galende, A., Romero, J. P., & Bermejo‐Pareja, F. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.08.048 · Cited by 26
Adenosine A2A receptor antagonists in Parkinson's disease: still in the running
Antonini, A., & Poewe, W. H. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70153-x · Cited by 15
Cited by
The role of JAK/STAT signaling pathway and its inhibitors in diseases.
Xin, P., Xu, X., Deng, C., Liu, S., Wang, Y., Zhou, X., Ma, H., Wei, D., & Sun, S. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106210 · Cited by 1,010
Romano, S., Savva, G. M., Bedarf, J. R., Charles, I. G., Hildebrand, F., & Narbad, A. (2021) · npj Parkinson's Disease · doi:10.1038/s41531-021-00156-z · Cited by 707
Endoplasmic Reticulum Stress and Unfolded Protein Response in Neurodegenerative Diseases
Ghemrawi, R., & Khair, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176127 · Cited by 398
Elfawy, H. A., & Das, B. (2019) · Life Sciences · doi:10.1016/j.lfs.2018.12.029 · Cited by 343
Mechanistic insights and perspectives involved in neuroprotective action of quercetin
Grewal, A. K., Singh, T. G., Sharma, D., Sharma, V., Singh, M., Rahman, M. H., Najda, A., Walasek-Janusz, M., Kamel, M., Albadrani, G. M., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111729 · Cited by 285
Metadata
- Authors
- Elbaz, A., Carcaillon, L., Kab, S., & Moisan, F.
- Venue
- Revue Neurologique
- Publisher
- Elsevier BV
- Published
- 2016-01
- Volume
- 172
- Issue
- 1
- Pages
- 14-26
- ISSN
- 0035-3787 (ISSN-L)
- OpenAlex
- W2207405009
- Cited by
- 445
- References
- 155
- FWCI
- 10.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.